APELLIS PHARMACEUTICALS, INC.

Profile

Company Names

APELLIS PHARMACEUTICALS, INC.

Addresses

6400 WESTWIND WAY, SUITE A, CRESTWOOD, KY 40014

201 E. JEFFERSON STREET, SUITE 312, LOUISVILLE, KY 40202

Phone Numbers

502-295-4607
502-569-1053

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$108,104,405.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2017-08-07 
$20,033,322.00 
$60,099,974.00 
$40,066,652.00 
Equity 
6
2015-12-24 
$47,135,951.00 
$47,135,951.00 
$0.00 
Equity 
5
2014-12-05 
$17,732,150.00 
$17,732,150.00 
$0.00 
Equity 
4
2013-07-30 
$17,842,487.00 
$24,000,000.00 
$6,157,513.00 
Equity 
3
2012-07-18 
$692,995.00 
$3,000,000.00 
$2,307,005.00 
Equity 
2
2011-05-20 
$2,967,500.00 
$4,213,000.00 
$1,245,500.00 
Equity 
1
2010-05-21 
$1,700,000.00 
$6,000,000.00 
$4,300,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
ADELMAN 
DIRECTOR
CERIMON PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  SIENTRA, INC.   |  ARAGON PHARMACEUTICALS, INC.   |  SOLSTICE BIOLOGICS LLC   |  LABRYS BIOLOGICS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  PRECISION BIOSCIENCES INC   |  METACRINE, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND II L.P.   |  TP THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.
STEVEN 
 
AXON 
EXECUTIVE OFFICER
APELLIS PHARMACEUTICALS, INC.
MARIE-CLAUDE 
 
BERNAL 
DIRECTOR
APELLIS PHARMACEUTICALS, INC.   |  GNUBIO INC.
GERALD 
 
CHAN 
DIRECTOR
CRITICAL BIOLOGICS CORP   |  MORNINGSIDE CHINA TMT FUND II, L.P.   |  SYNCHRONEURON INC.   |  NATURAL POLYMER INTERNATIONAL CORP   |  APELLIS PHARMACEUTICALS, INC.   |  MORNINGSIDE CHINA TMT FUND III CO-INVESTMENT, L.P.   |  MORNINGSIDE CHINA TMT SPECIAL OPPORTUNITY FUND, L.P.   |  MORNINGSIDE CHINA TMT FUND III, L.P.   |  MORNINGSIDE CHINA TMT TOP UP FUND LP   |  MORNINGSIDE CHINA TMT FUND IV CO-INVESTMENT, L.P.   |  MORNINGSIDE CHINA TMT SPECIAL OPPORTUNITY FUND II, L.P.   |  MORNINGSIDE CHINA TMT FUND IV, L.P.   |  ATEA PHARMACEUTICALS, INC.   |  GOOD FOODIE CO   |  KEZAR LIFE SCIENCES, INC.   |  APNIMED, INC.   |  STAVROS TECHNOLOGIES, INC.   |  STEALTH BIOTHERAPEUTICS CORP   |  LUMIRADX LTD   |  LINUS HEALTH, INC.   |  ANACONDA, INC.   |  NEUTROLIS INC.   |  COGNITO THERAPEUTICS LTD.   |  COGNITO THERAPEUTICS GROUP, INC.
BIHUA 
 
CHEN 
DIRECTOR
CORMORANT GLOBAL HEALTHCARE FUND, LP   |  CORMORANT GLOBAL HEALTHCARE OFFSHORE FUND, LTD.   |  APELLIS PHARMACEUTICALS, INC.   |  C4 THERAPEUTICS, INC.   |  CORMORANT PRIVATE HEALTHCARE FUND I, LP   |  TP THERAPEUTICS, INC.   |  TP THERAPEUTICS, INC   |  KEZAR LIFE SCIENCES, INC.   |  ATEA PHARMACEUTICALS, INC.   |  CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND II, LP   |  CORMORANT PRIVATE HEALTHCARE FUND II, LP   |  ATIA VISION, INC.   |  SUPIRA MEDICAL, INC.   |  CORMORANT PRIVATE HEALTHCARE FUND III LP   |  CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND III LP   |  ADONA MEDICAL, INC.   |  BLOSSOMHILL THERAPEUTICS, INC.   |  CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND IV LP   |  CORMORANT PRIVATE HEALTHCARE FUND IV LP   |  TIOGA CARDIOVASCULAR, INC.   |  BIVACOR INC.   |  CHROMA MEDICINE, INC.   |  BIOVENTRIX INC   |  TIGER BIOTHERAPEUTICS INC.   |  CORMORANT PRIVATE HEALTHCARE FUND V LP   |  CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND V LP   |  GRAVITON BIOSCIENCE CORP   |  INTERIUS BIOTHERAPEUTICS, INC.   |  CORMORANT PRIVATE HEALTHCARE FUND VI, LP   |  CORMORANT PRIVATE HEALTHCARE OFFSHORE FUND VI, LP   |  AKURA MEDICAL, INC.
DAVID 
 
DARST 
DIRECTOR
APELLIS PHARMACEUTICALS, INC.   |  RGENIX, INC.   |  INSPIRNA, INC.
DAVID 
 
DARST, JR. 
DIRECTOR
APELLIS PHARMACEUTICALS, INC.
PASCAL 
 
DESCHATELETS 
EXECUTIVE OFFICER, DIRECTOR
APELLIS PHARMACEUTICALS, INC.   |  NX PHARMAGEN INC.   |  REVON SYSTEMS, LLC
A. 
SINCLAIR 
DUNLOP 
DIRECTOR
APELLIS PHARMACEUTICALS, INC.
SINCLAIR 
 
DUNLOP 
DIRECTOR
MEDIQUEST THERAPEUTICS INC   |  MAXCYTE, INC.   |  APELLIS PHARMACEUTICALS, INC.
CEDRIC 
 
FRANCOIS 
EXECUTIVE OFFICER, DIRECTOR
APELLIS PHARMACEUTICALS, INC.   |  NX PHARMAGEN INC.   |  REVON SYSTEMS, LLC   |  REVON SYSTEMS, INC.   |  LIBERATE MEDICAL, INC.   |  ACUAMARK DIAGNOSTICS, INC.
DANIEL 
 
GEFFKEN 
EXECUTIVE OFFICER
SYNLOGIC, INC.   |  LYSOSOMAL THERAPEUTICS, INC.   |  OPSONIX, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  ARCTURUS THERAPEUTICS LTD.   |  VEDANTRA PHARMACEUTICALS, INC.   |  SG DAN HOLDINGS LLC   |  ELICIO THERAPEUTICS, INC.   |  WINDTREE THERAPEUTICS INC /DE/   |  PROMIS NEUROSCIENCES INC.   |  CALCIMEDICA SUBSIDIARY, INC.   |  CALCIMEDICA, INC.
STEPHEN 
 
GILLIES 
DIRECTOR
APELLIS PHARMACEUTICALS, INC.
FEDERICO 
 
GROSSI 
EXECUTIVE OFFICER
APELLIS PHARMACEUTICALS, INC.
MAHA 
 
KATABI 
DIRECTOR
EFFECTOR THERAPEUTICS, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  AEROVATE THERAPEUTICS, INC.   |  VERA THERAPEUTICS, INC.   |  GYROSCOPE THERAPEUTICS LTD   |  QUANTA THERAPEUTICS, INC.   |  SOFINNOVA VENTURE PARTNERS XI, L.P.   |  RAYZEBIO, INC.   |  MAREA THERAPEUTICS, INC.   |  SOFINNOVA VENTURE PARTNERS XII, L.P.   |  STAR THERAPEUTICS LLC
ROBERT 
 
KIM 
EXECUTIVE OFFICER
HANOVER PACIFIC, LLC   |  NAPIER PARK QUALIFIED INVESTOR PORTFOLIOS - NAPIER PARK ABSOLUTE RETURN MUNI STRATEGY PORTFOLIO   |  APELLIS PHARMACEUTICALS, INC.
ALEC 
 
MACHIELS 
DIRECTOR
APELLIS PHARMACEUTICALS, INC.   |  CREATIVE REALITIES, INC.   |  REVON SYSTEMS, LLC   |  REVON SYSTEMS, INC.   |  LIBERATE MEDICAL, INC.   |  CSS HOLDCO LLC   |  CONSUMER SLEEP SOLUTIONS LLC   |  COLIFT METALS CO-INVESTMENT PARTNERS LP
STEPHANIE 
 
O-BRIEN 
DIRECTOR
ADURO BIOTECH   |  BIDDINGFORGOOD, INC.   |  ADURO BIOTECH, INC.   |  NATURAL POLYMER INTERNATIONAL CORP   |  APELLIS PHARMACEUTICALS, INC.   |  VIGEO THERAPEUTICS, INC.   |  PINTEON THERAPEUTICS, INC.   |  2020, INC.
DOUGLAS 
 
ONSI 
DIRECTOR
SEQUOIA PHARMACEUTICALS INC   |  ANEXON, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  TETRALOGIC PHARMACEUTICALS CORP   |  LEAP THERAPEUTICS, INC.
NICOLE 
 
PERRY 
EXECUTIVE OFFICER
APELLIS PHARMACEUTICALS, INC.
DAVID 
 
WATSON 
EXECUTIVE OFFICER
PENSATO EUROPA FUND LTD   |  FOUNDERS FUND I, L.L.L.P.   |  BRLEND, L.L.C.   |  FOUNDERS PROPERTIES INCOME FUND II, L.L.L.P.   |  INVESTORMILL INC.   |  REVON SYSTEMS, LLC   |  APELLIS PHARMACEUTICALS, INC.   |  PENSATO EUROPA FUND LP   |  CARDHOLDER MANAGEMENT SERVICES, INC.   |  PENSATO EUROPEAN EQUITY FUND LTD   |  PENSATO EUROPEAN EQUITY FUND LP   |  RWC PENSATO EUROPA FUND LTD.   |  RWC EUROPE FUND LTD.   |  RWC EUROPE FUND LP   |  RWC PENSATO EUROPA FUND LP   |  ARTC HOLDINGS, LLC   |  CARDWORKS,INC.   |  TRIAGENICS, INC   |  VOYAGER RED STAG, LP   |  RISKADVISOR, INC.   |  JOHNSTONE SUPPLY HOLDINGS, LLC   |  VOYAGER HORSESHOE, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-08-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-08-07 
2016-02-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-12-24 
2016-01-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-12-24 
2015-06-09
D/A
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-12-05 
2014-12-17
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-12-05 
2014-08-27
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
2013-08-05
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2013-07-30 
2012-07-25
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2012-07-18 
2011-06-20
D/A
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2011-05-20 
2011-06-01
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2011-05-20 
2010-05-21
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2010-05-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#